Mangalam Drugs And Organics: The financial results for the period ended September 30, 2026
Mangalam Drugs And Organics (MANGALAM) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹48.5 crore.
What happened
Mangalam Drugs And Organics (MANGALAM) filed a disclosure with the exchanges on 5 November 2026 at 06:43 PM titled "The financial results for the period ended September 30, 2026".
From the filing: "Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026."
Company snapshot
Mangalam Drugs And Organics is a micro-cap company, with a market value of about ₹48.5 crore.
The stock last traded at ₹30.64, against a 52-week range of ₹22.8–₹66.19 (53.7% below the high).
Before this filing the shares had moved +1.9% over the month and +9.9% over three months. Average daily turnover over the last 20 sessions was about ₹0.09 crore.
Promoters held 35.65% at the end of Q1 FY27. Foreign institutions owned 0.11% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 57 | -13.8 | -8.72 |
| Q2 FY26 | 107 | -21.1 | -13.36 |
| Q3 FY26 | 58 | -9.8 | -6.21 |
| Q4 FY26 | 67 | -13.4 | -8.48 |
| Q1 FY27 | 57 | -7.6 | -4.83 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 2.9% on average the next trading day and was down 1.2% on average after five days (2 filings with price data).
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 12 Aug 2026 | Declaration Of Un-Audited Financial Results (Standalone &… | +2.9% | −1.2% |
| 12 Aug 2026 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th… | +2.9% | −1.2% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.